Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

Study Shows Older Mesothelioma Patients Less Likely To Have Chemotherapy

Research conducted by the Asbestos Diseases Research Institute in Sydney, Australia is calling into question whether old mesothelioma patients are being treated with the same attention as is true of their younger counterparts. The study showed that among more than 900 mesothelioma patients, the older a patient was at the time of diagnosis, the lower the chances that they would be treated using the most popular cancer protocol.

Chemotherapy using Alimta is the gold standard of mesothelioma treatments

There are a number of innovative treatments being explored in the treatment of malignant mesothelioma, but the standard protocol remains a combination of surgery, chemotherapy and radiation therapy. Studies have shown a significant increase in survival time for mesothelioma patients who are treated using Alimta and cisplatin together.

Despite the easy availability of this mesothelioma treatment, the Australian study shows that as patients’ diagnosis age advances, the chances that they are treated using chemotherapy diminishes, and so too does their survival time.

Median survival time impacted by chemotherapy

The statistics that were collected among the 910 mesothelioma patients in the study were stark: the number of patients diagnosed when they were younger than 70 and when they were between the ages of 70 and 80 was roughly the same at forty-one percent and forty percent respectively, with the rest of patients being over 80 years old. But while 66 percent of those in the under 70 group were given chemotherapy, the group between the age of 70 and 80 saw just 35 percent treated with the potent drug. The survival difference between the two groups was just as significant, with the under-70 group surviving a median of 13.5 months and the group between 70 and 80 having a median survival of only 9.5 months.

In the under 70 group, the 34 percent that did not receive chemotherapy had a median survival of just 7 months compared to 16.8 months for those who did. Similarly, the 70-to-80 year olds who did not get chemotherapy had a median survival of 5.8 months, while those who did have the treatment had a median survival of 13.9 months. The study did not provide a reason for the disparity in administration of the treatment.

If you or someone you love has been diagnosed with mesothelioma, it is important that you have a good understanding of the advantages of each of the treatments available to you, no matter what your age. For more information on your options, contact us at 1-800-692-8608.


Terri Oppenheimer

Terri Oppenheimer is an experienced blog writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of expertise include health, medical research, and law.

Get Your FREE Resources Sent Overnight

  • New treatment options
  • Veterans benefits & claims
  • $30 Billion asbestos trust fund information

– Or Call –

Site Navigation

Where can I

Get Additional Help?

For over 20 years, we’ve provided the best FREE resources to mesothelioma patients and loved ones. Our resources include information on the leading treatment options and best doctors in your area; lessons learned from survivors; claims and benefits specifically for Veterans; and how to access your share of billions of dollars in trust fund money.

Get Your FREE Resources Sent Overnight

  • New Treatment Options
  • Veteran's Benefits & Claims
  • $30 Billion Asbestos Trust Fund Information

– Or Call –

We are here to help you


If you've been diagnosed with asbestos-related cancer, contact us at 1-800-692-8608 to find out if you are eligible to receive compensation. You can also fill out the form above to receive FREE information.

$30 Billion Asbestos Trusts
Get Started